搜索结果 | 泌尿系统常见疾病循证医学证据

泌尿系统常见疾病循证医学证据

首页搜索结果

证据分类

搜索结果

共搜索到1条与stockholder in: Aurora Oncology有关的结果

Reduced E-cadherin expression as a prognostic factor in non-muscle-invasive bladder cancer: A systematic review and meta-analysis

 2020 年发布于 Toxicological Sciences 104 卷第 4 期

Yang T. Fan J. Liang H. He D. Zeng X. Wu K.

Bladder cancer Pd-1 Pd-l1 atezolizumab avelumab biomarkers durvalumab immunotherapy nivolumab pembrolizumab Urogen licenses/patents: University of Colorado research support: Medivation/Astellas stockholder in: Aurora Oncology PrecisionProfile other: IOS Press (editorial responsibilities compensated).The other authors report no conflicts of interest.
文献简介 原文链接